Stay updated on IRX-2 Combo in Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.

Latest updates to the IRX-2 Combo in Gastric Cancer Clinical Trial page
- Check3 days agoChange DetectedThe footer revision label changes from v3.7.2 to v3.8.0; the page content remains a 403 Forbidden error.SummaryDifference0.2%

- Check10 days agoChange DetectedA sitewide notice announces that NIH is transitioning to using “Super Intelligence” instead of “Artificial Intelligence” in its content, with updates and FAQs available.SummaryDifference1%

- Check17 days agoChange DetectedThe 403 error message and its Home link disappeared, and the site revision changed to v3.7.2. The study details are not visible on the page.SummaryDifference0.6%

- Check24 days agoChange DetectedThe footer revision identifier changed from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check45 days agoChange DetectedRevision: v3.7.0 has been added to the page footer. Several items in the Study Documents section were removed, including links to the Study Protocol and Statistical Analysis Plan, along with other related documents and labels.SummaryDifference20%

- Check66 days agoChange DetectedThe page's revision label was updated to v3.6.6, replacing the previous v3.6.5, indicating a minor publish update to the page's revision history.SummaryDifference0.1%

Stay in the know with updates to IRX-2 Combo in Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IRX-2 Combo in Gastric Cancer Clinical Trial page.